Heparin for RAO Post-Transradial Angiography in AIS

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 440 participants.

Also called NCT07162064

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 440 participants (enrolled count) (from the registry)
Sponsor
  • Xiang Luo Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07162064
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07162064. Randomized; double masking; primary purpose prevention. Start 2025-08-04 (actual); primary completion 2026-01-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Heparin for RAO Post-Transradial Angiography in AIS
Condition
Acute Ischemic Stroke
Intervention (Drug)
Heparin - Therapeutic dosage
Intervention (Drug)
Saline (0.9% NaCl)
Lead sponsor
Xiang Luo (class: other)

Record details

Record id
cardio:ct-nct07162064
Content hash
d27845c32c605bc70984334d1b96f03295d88c926fe02ca586237b6936cbb075